Nathan Vandergrift

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120

Maternal humoral immune correlates of peripartum transmission of clade C HIV-1 in the setting of peripartum antiretrovirals

Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

Maternal binding and neutralizing IgG responses targeting the C terminal region of the V3 loop are predictive of reduced peripartum HIV-1 transmission risk

Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial

HIV-1 envelope mimicry of host enzyme kynureninase does not disrupt tryptophan metabolism

Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques

Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies

Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus

Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages

Strain-specific V3 and CD4 binding site autologous HIV-1 neutralizing antibodies select neutralization-resistant viruses

HIV-1 vaccines. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

Comprehensive characterization of the transmitted/founder env genes from a single MSM cohort in China

Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission

Comparison of immunogenicity in rhesus macaques of transmitted-founder, HIV-1 group M consensus, and trivalent mosaic envelope vaccines formulated as a DNA prime, NYVAC, and envelope protein boost

Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses

Polyreactivity and autoreactivity among HIV-1 antibodies

Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition